JP2005343851A - Peptide derived from fishes and method for producing the same - Google Patents

Peptide derived from fishes and method for producing the same Download PDF

Info

Publication number
JP2005343851A
JP2005343851A JP2004167313A JP2004167313A JP2005343851A JP 2005343851 A JP2005343851 A JP 2005343851A JP 2004167313 A JP2004167313 A JP 2004167313A JP 2004167313 A JP2004167313 A JP 2004167313A JP 2005343851 A JP2005343851 A JP 2005343851A
Authority
JP
Japan
Prior art keywords
elastin
fish
peptide
enzyme
alkali
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004167313A
Other languages
Japanese (ja)
Inventor
Koichi Ogawa
耕一 小川
Misako Nakaba
操子 中場
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashikane Sangyo Co Ltd
Original Assignee
Hayashikane Sangyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashikane Sangyo Co Ltd filed Critical Hayashikane Sangyo Co Ltd
Priority to JP2004167313A priority Critical patent/JP2005343851A/en
Publication of JP2005343851A publication Critical patent/JP2005343851A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a peptide characterized as comprising desmosine and isodesmosine which are amino acids contained only in elastin at a high concentration and definitely discriminated from collagen peptide. <P>SOLUTION: The peptide obtained by degrading a tissue composed of elastic fibers of fishes with a high elastin content, especially an aortic bulb with an enzyme, an acid or an alkali or its aqueous solution is provided. Furthermore, a method for producing the peptide comprising degrading the tissue composed of the elastic fibers of the fishes with the high elastin content with the enzyme, acid or alkali. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、魚類の弾性繊維により構成される組織、特に、心臓動脈球もしくは他の動脈組織を原料として得られる、魚特有の味や臭いがない分解物(ペプチド)及びその製造方法に関する。この分解物は各種医療用生体素材、化粧品素材及び健康食品素材等として有用な可溶性のエラスチンペプチドを高濃度で含有している。   The present invention relates to a degradation product (peptide) that is obtained from a tissue composed of elastic fibers of fish, in particular, a heart arterial sphere or other arterial tissue, and has no fish-specific taste and odor, and a method for producing the same. This degradation product contains soluble elastin peptides useful as various medical biomaterials, cosmetic materials, health food materials, and the like at high concentrations.

エラスチンは動物組織中では項靭帯や動脈のような常に伸縮性、弾力性が求められる組織に存在している。また、僅かではあるが皮膚にも弾性に関与する成分としてコラーゲンと共に真皮結合組織に存在している。加齢や紫外線により皮膚中のエラスチンは減少し、またエラスチン自体が変性して本来の弾性を保てなくなり、シワ、タルミの原因となる。このためエラスチンは化粧品や健康食品分野への応用が有効とされ、現在多くの製品に適用されている。   Elastin is present in animal tissues such as the ligaments and arteries that always require elasticity and elasticity. Moreover, although it is slight, it exists in dermis connective tissue with collagen as a component which is concerned with elasticity. Elastin in the skin is reduced by aging and ultraviolet rays, and elastin itself is denatured and cannot maintain its original elasticity, causing wrinkles and tarmi. For this reason, elastin is effective in the cosmetics and health food fields, and is currently applied to many products.

また、エラスチンは血管構成成分として重要な役割を担っていることから各種血管病変に関与していると考えられ、医薬品分野での利用も検討されている。   In addition, since elastin plays an important role as a vascular component, it is considered to be involved in various vascular lesions, and its use in the pharmaceutical field is also being studied.

エラスチンはその性質から、酸、アルカリ等の各種溶媒に対して強い抵抗性を示すため、化粧品や食品で利用するためには可溶化する必要がある。低分子化することで水や各種溶媒への溶解度を高め、生体内での吸収率が高くなると考えられ、生理活性を有することが期待できる。   Due to its properties, elastin exhibits strong resistance to various solvents such as acids and alkalis, so it must be solubilized for use in cosmetics and foods. By reducing the molecular weight, it is considered that the solubility in water and various solvents is increased and the absorption rate in vivo is increased, and it can be expected to have physiological activity.

エラスチンの生理的効果としては、外用剤の効果として、皮膚や頭髪に適用することで、質感の改善が見られること(特開昭60-258107号公報)、また、コラーゲン、コンドロイチンと共に使用することで、創傷治癒にも効果があること(特開昭60-64909号公報)が知られている。さらにこのコラーゲン、コンドロイチン、エラスチンの3種の成分は、経口摂取することでもその効果が認められること(特開2003-55255公報)が知られている。以上のような背景から、現在では機能性素材として、飲食品や化粧品分野で盛んに利用されるようになっている。   As the physiological effect of elastin, the effect of external preparations can be improved by applying it to the skin and hair (Japanese Patent Laid-Open No. 60-258107), and it should be used together with collagen and chondroitin Thus, it is known that it has an effect on wound healing (Japanese Patent Laid-Open No. 60-64909). Furthermore, it is known that the effects of these three components of collagen, chondroitin, and elastin are recognized even when taken orally (Japanese Patent Laid-Open No. 2003-55255). From the background as described above, it is now actively used as a functional material in the food and drink and cosmetic fields.

エラスチン高含有組織としては牛項靭帯が知られているが、日本国内で狂牛病感染の牛が発見され、また豚口蹄疫のような家畜疫病の発生によって、哺乳類由来のエラスチンは敬遠される傾向にある。健康食品素材として既に市場の構築されたコラーゲンペプチドでも、殆どが海洋性素材を利用した製品が主流になっており、畜産物由来素材の市場は次第に縮小しつつある。エラスチンペプチドについても同様のことが考えられ、牛項靭帯を原料としたエラスチンペプチドに代わる素材が必要になっている。   Bovine ligament is known as a high-elastin-containing tissue, but cows infected with mad cow disease have been found in Japan, and elastin derived from mammals tends to be avoided due to the occurrence of livestock plague such as swine and foot-and-mouth disease It is in. Even for collagen peptides that have already been established as health food materials, most products using marine materials have become mainstream, and the market for livestock-derived materials is gradually shrinking. The same applies to elastin peptides, and materials that replace elastin peptides made from bovine ligaments are needed.

以上のような理由から、より安全な魚類由来のエラスチンペプチドが注目されるようになっている。   For the reasons as described above, a safer fish-derived elastin peptide has attracted attention.

エラスチンを可溶化する方法は、例えば、特開昭53-101592号公報や特開昭60-258107号公報に記載されているが、これらの方法はエラスチンを豊富に含む牛や豚などの哺乳類の項靭帯を原料としたものである。   Methods for solubilizing elastin are described, for example, in JP-A-53-101592 and JP-A-60-258107. These methods are used in mammals such as cattle and pigs that are rich in elastin. The material is a knot ligament.

魚類素材を原料としてエラスチンペプチドを得る従来の方法は、魚皮を原料として使用するものであり、洗浄した魚皮から酸性水溶液を使用してコラーゲンと共に魚皮中に微量に含まれるエラスチンを抽出する方法(特開平5−202097号公報)、洗浄した魚皮をエラスターゼ処理する方法(特開平2001−72572号公報)等が知られている。   The conventional method for obtaining elastin peptides from fish materials is to use fish skin as a raw material, and extract elastin contained in trace amounts in the fish skin together with collagen from the washed fish skin using an acidic aqueous solution. A method (JP-A-5-202097), a method of treating washed fish skin with elastase (JP-A-2001-72572), and the like are known.

しかしながら、本来、皮膚はコラーゲンをはじめとする膠原繊維が主体であり、エラスチンは極微量しか含まれていないことが知られている。ヒトの場合、乾燥皮膚真皮中にコラーゲンは約80%含まれるのに対して、エラスチンは4%程度とされている。   However, it is known that the skin is mainly composed of collagen fibers such as collagen and contains only a very small amount of elastin. In humans, about 80% of collagen is contained in dry skin dermis, whereas elastin is about 4%.

同様に、魚皮の主成分も膠原繊維であり、アミノ酸組成からも魚皮の主成分は、ほぼコラーゲンであることが認められる。さらにエラスチンを含有する証明となるデスモシン、イソデスモシンは殆ど含まれていない。以上のことから、魚由来の高濃度のエラスチンを得るための原料として、魚皮は不適当である。   Similarly, the main component of fish skin is also collagen fibers, and it is recognized from the amino acid composition that the main component of fish skin is almost collagen. Furthermore, it contains almost no desmosine or isodesmosine which proves that it contains elastin. From the above, fish skin is unsuitable as a raw material for obtaining a high concentration of elastin derived from fish.

これに対し主成分が弾性繊維である動脈球はエラスチンタンパク質としての特徴を持ち、またデスモシン、イソデスモシン含量も、通常の魚エラスチン中に含まれる量とほぼ同じである。   In contrast, arterial spheres, whose main component is elastic fibers, have the characteristics of elastin protein, and the contents of desmosine and isodesmosine are almost the same as those contained in normal fish elastin.

本発明の目的は、魚類由来弾性繊維を原料として、エラスチンに特有のアミノ酸であるデスモシン、イソデスモシンを高濃度に含有し、健康食品や化粧品等にも好適に使用でき、魚特有の味や臭いが少なく、安全性に優れた魚類弾性繊維由来ペプチド及びその製造方法を提供することにある。   The object of the present invention is to use fish-derived elastic fiber as a raw material, it contains desmosine and isodesmosine, which are amino acids peculiar to elastin, and can be suitably used for health foods and cosmetics, and has a fish-specific taste and smell. It is an object of the present invention to provide a fish elastic fiber-derived peptide having a low level of safety and a method for producing the same.

本発明によれば、エラスチン含有量の高い魚類の弾性繊維により構成される組織を酵素、酸又はアルカリにより分解して得られるペプチド又はその水溶液が提供される。   ADVANTAGE OF THE INVENTION According to this invention, the peptide obtained by decomposing | disassembling the structure | tissue comprised with the elastic fiber of fish with high elastin content with an enzyme, an acid, or an alkali, or its aqueous solution is provided.

本発明によれば、更に、エラスチン含有量の高い魚類の弾性繊維により構成される組織を酵素、酸又はアルカリにより分解することからなるペプチドの製造方法が提供される。   According to the present invention, there is further provided a method for producing a peptide comprising decomposing a tissue composed of fish elastic fibers having a high elastin content with an enzyme, acid or alkali.

上記目的を達成するために、本発明によれば、弾性繊維により構成される組織として、特に、エラスチンを高濃度で含有する(通常全タンパク質中30〜50%)弾性繊維より構成される組織、特に、心臓周辺の血管、好ましくは動脈球が原料として用いられる。   In order to achieve the above-mentioned object, according to the present invention, as a tissue constituted by elastic fibers, in particular, a tissue constituted by elastic fibers containing elastin at a high concentration (usually 30 to 50% in the total protein), In particular, blood vessels around the heart, preferably arterial spheres, are used as raw materials.

上記原料より血液、脂質、可溶性タンパク質、コラーゲン質を除去し、回収した不溶性タンパク質を酵素、もしくは、酸又はアルカリで分解して可溶性のペプチドを得ることができる。   Blood, lipids, soluble proteins, and collagenous substances are removed from the above raw materials, and the recovered insoluble protein can be decomposed with an enzyme, acid, or alkali to obtain a soluble peptide.

本発明によれば、従来の魚皮由来の、コラーゲンを主体とするエラスチン含有ペプチドと比較して、エラスチンに特有のアミノ酸構成を持ち、更にエラスチンに特有のアミノ酸であるデスモシン、イソデスモシンを魚皮中に含まれる量より多く含むペプチドを得ることができる。   According to the present invention, compared to conventional fish skin-derived elastin-containing peptides mainly composed of collagen, it has an amino acid structure unique to elastin, and further, desmosine and isodesmosine, which are amino acids unique to elastin, are contained in fish skin. A peptide containing more than the amount contained in can be obtained.

本発明による魚由来ペプチドは、上記した通り、エラスチン特有のアミノ酸組成を持ち、エラスチンにのみ含まれるアミノ酸であるデスモシン、イソデスモシンを魚皮よりはるかに多く含有し、かつヒドロキシプロリンを1%以下、ヒドロキシリジンを1%以下の量で含有している。   As described above, the fish-derived peptide according to the present invention has an amino acid composition unique to elastin, contains much more desmosine and isodesmosine, which are amino acids contained only in elastin, and contains 1% or less hydroxyproline, It contains lysine in an amount of 1% or less.

本発明において用いられる魚動脈球の起源は特に制限はないが、心臓より動脈球を回収するためにある程度の大きさが必要であり、例えば、カツオ、マグロ、カジキ、タラ、ハマチ、ブリ、サケ、マス等から得られる魚類原料を用いることができる。中でも、大量かつ安定的に入手できる魚種として、カツオ、マグロ、タラ、ハマチ、サケから得られる動脈球が好ましい。   The origin of the fish arterial sphere used in the present invention is not particularly limited, but a certain size is required to collect the arterial sphere from the heart. For example, skipjack, tuna, swordfish, cod, yellowtail, yellowtail, salmon Fish raw materials obtained from trout and the like can be used. Among them, arterial spheres obtained from skipjack, tuna, cod, yellowtail, and salmon are preferred as fish species that can be stably obtained in large quantities.

本発明のペプチドは、慣用の化粧料成分中に配合することにより化粧料の有効成分として、また、健康食品中に配合することにより健康食品の有効成分として使用することができる。本発明の弾性繊維由来魚類ペプチドを含有する化粧料を皮膚に塗布することにより、皮膚の弾力性、保水性等の質感の改善が期待され、また、本発明のペプチドを含有する健康食品を摂取することにより、同様に、皮膚の質感等の改善が期待される。   The peptide of the present invention can be used as an active ingredient of cosmetics by blending in conventional cosmetic ingredients, and as an active ingredient of health foods by blending in health foods. By applying a cosmetic containing the elastic fiber-derived fish peptide of the present invention to the skin, it is expected to improve the texture of the skin, such as elasticity and water retention, and ingesting a health food containing the peptide of the present invention By doing so, the improvement of the texture of the skin and the like is also expected.

本発明のペプチドを化粧料の有効成分として使用する場合には、該ペプチドは、通常、化粧料成分の合計重量の0.01%〜1%の量で使用され、また、本発明のペプチドを健康食品の有効成分として使用する場合には、該ペプチドは、通常、健康食品の構成成分の合計重量の1%〜5%の量で使用されるのが好ましい。またいずれもこれより高濃度もしくは低濃度でも使用することが可能である。   When the peptide of the present invention is used as an active ingredient of a cosmetic, the peptide is usually used in an amount of 0.01% to 1% of the total weight of the cosmetic ingredients, and the peptide of the present invention is used as a health food. When used as an active ingredient, the peptide is usually preferably used in an amount of 1% to 5% of the total weight of the components of the health food. Both can be used at higher or lower concentrations.

本発明の魚類由来のエラスチン含有ペプチドは、以下に例示する製造法により製造することができるが、これに限定されるものではなく、通常の硬タンパク質可溶化方法であるアルカリ-エタノール法、酸分解法等も使用できる。   The fish-derived elastin-containing peptide of the present invention can be produced by the production method exemplified below, but is not limited thereto, and is an ordinary hard protein solubilization method such as an alkali-ethanol method, acid degradation. Laws can also be used.

製造法1
心臓より動脈球を採取し、流水洗浄にて血液を除去する。原料の前処理としては、原料の洗浄及びその後の抽出操作を容易にするために、アルカリに組織を浸漬する。この場合のアルカリは、水酸化ナトリウム、水酸化カルシウム、好ましくは水酸化ナトリウムの溶液である。濃度は0.01Nから0.1N、好ましくは0.02Nである。浸漬温度は20℃以下、期間は12時間〜5日間程度であり、好ましくは3日間である。また浸漬中は溶媒を1日につき2回以上取り替えることが好ましい。なおこれらの前処理の条件は魚種により原料組織の溶媒に対する抵抗性が異なる為、これに限定されるものではなく、原料魚種により事前に検討することが望ましい。
Production method 1
Arterial spheres are collected from the heart, and blood is removed by washing with running water. As the pretreatment of the raw material, the tissue is immersed in an alkali in order to facilitate the cleaning of the raw material and the subsequent extraction operation. The alkali in this case is a solution of sodium hydroxide, calcium hydroxide, preferably sodium hydroxide. The concentration is 0.01N to 0.1N, preferably 0.02N. The immersion temperature is 20 ° C. or less, and the period is about 12 hours to 5 days, preferably 3 days. During immersion, it is preferable to change the solvent at least twice a day. The conditions for these pretreatments are not limited to this because the resistance of the raw material tissue to the solvent differs depending on the fish species, and it is desirable to examine in advance depending on the raw fish species.

浸漬後、流水洗浄により過剰のアルカリを除去し、原料の中和を行う。洗浄後、これに蒸留水を加え、95℃に加熱し、コラーゲン質及び脂質の除去を行う。これを抽出原料として酵素分解し、可溶性エラスチンを得る。分解に使用する酵素としては、食品、医薬品、化粧品業界にて使用できるものであれば全て使用できるが、力価の大きいものが好ましく、例えばAlcalase2.4L FG(Nnovozymes製)、プロチンAC-10F(大和化成製)、プロテアーゼN「アマノ」G、ペプシン(天野エンザイム製)等が望ましく、分解条件はこれらの使用酵素ごとに決定される。添加量としては通常当業界でタンパク質分解に用いられる量であり、例えば酵素と基質の重量比は1:5000〜1:10,000である。またこれらの酵素は単独で使用するよりも、2種を組み合わせて使用することが好ましい。反応終了後、加熱失活を行い、化粧品原料として好ましいpHである4付近に調整した後、濾過により残渣を分離する。このとき必要であれば活性炭、濾過助剤等を用いて不溶物を取り除き、エラスチン含有ペプチド溶液を得る。溶液で使用する場合は、ここでメンブレンフィルターを使用して、除菌濾過を行う。   After soaking, excess alkali is removed by washing with running water to neutralize the raw material. After washing, distilled water is added thereto and heated to 95 ° C. to remove collagenous substances and lipids. This is enzymatically decomposed as a raw material for extraction to obtain soluble elastin. Enzymes used for degradation can be used as long as they can be used in the food, pharmaceutical and cosmetic industries, but those having a high titer are preferable, such as Alcalase 2.4L FG (Nnovozymes), Protin AC-10F ( Daiwa Kasei), protease N “Amano” G, pepsin (manufactured by Amano Enzyme) and the like are desirable, and the degradation conditions are determined for each of these enzymes used. The amount added is usually an amount used for proteolysis in the art, for example, the weight ratio of enzyme to substrate is 1: 5000 to 1: 10,000. These enzymes are preferably used in combination of two types rather than using them alone. After completion of the reaction, heat inactivation is performed, and the pH is adjusted to about 4 which is a preferable pH as a cosmetic raw material, and then the residue is separated by filtration. At this time, if necessary, the insoluble matter is removed using activated carbon, a filter aid or the like to obtain an elastin-containing peptide solution. When using it as a solution, sterilization filtration is performed using a membrane filter here.

酵素分解物はさらに濃縮し噴霧乾燥することで、化粧品原料だけでなく、健康食品原料としても使用可能である。   The enzyme degradation product is further concentrated and spray-dried, so that it can be used not only as a cosmetic raw material but also as a health food raw material.

製造法2
製造法1と同様にアルカリにて前処理を行った原料を用いて、無機酸溶液中にて加熱して、酸可溶性エラスチンペプチドを得る。使用する酸としては、塩酸、シュウ酸が好ましく、塩酸では1N、80℃、シュウ酸では0.25M、90℃での処理が好ましい。可溶化後、アルカリにて中和を行う。このとき使用するアルカリとしては水酸化ナトリウム、水酸化カルシウムが好ましく、特にシュウ酸を用いて可溶化した場合には、これを完全に除去するために、水酸化カルシウムでの中和が必須である。ろ過により残渣および生成した塩を除去し、必要であれば脱塩を行い、エラスチン含有ペプチド溶液を得る。
Manufacturing method 2
In the same manner as in Production Method 1, a raw material pretreated with an alkali is used and heated in an inorganic acid solution to obtain an acid-soluble elastin peptide. As the acid to be used, hydrochloric acid and oxalic acid are preferable. Treatment with 1N, 80 ° C. for hydrochloric acid and 0.25 M, 90 ° C. for oxalic acid is preferable. After solubilization, neutralization with alkali is performed. As the alkali used at this time, sodium hydroxide and calcium hydroxide are preferable. In particular, when solubilized with oxalic acid, neutralization with calcium hydroxide is indispensable in order to completely remove it. . Residues and generated salts are removed by filtration, and desalting is performed if necessary to obtain an elastin-containing peptide solution.

製造法3
製造法1と同様にアルカリにて前処理を行った原料を用いて、1N-NaOH、80%EtOH溶液にて室温におき、可溶化する。濾過により残渣を除去したのち、pH4附近に調整し、必要であれば脱塩を行い、エラスチン含有ペプチド溶液を得る。
Production method 3
In the same manner as in Production Method 1, using raw materials pretreated with alkali, solubilize in 1N-NaOH, 80% EtOH solution at room temperature. After removing the residue by filtration, the pH is adjusted to around 4, and if necessary, desalting is performed to obtain an elastin-containing peptide solution.

本発明の実施例を以下に示す。   Examples of the present invention are shown below.

実施例1
新鮮なカツオ心臓動脈球100gを蒸留水にて流水洗浄し、内部の血液を除去する。洗浄した動脈球を0.02N水酸化ナトリウム溶液にて常温で3日間浸漬し、残存する血液を除去する。流水洗浄後、塩酸にて中和し、3倍容の蒸留水を加えて95℃にて加熱殺菌する。上清を取り除き、脂質と共にコラーゲン質を除去する。これを抽出原料とし、フードカッターにて細片化し、酵素Alcalase2.4L FGを1.0%加え、水酸化ナトリウムにてpH8.5とした溶液中で6時間分解する。分解物に塩酸を加えてpH3とし、ペプシン(天野エンサ゛イム製)を1:10,000となるよう添加し、16時間分解する。pH4に調整し、85℃以上達温で酵素失活を行い、層濾過にて精製後噴霧乾燥し、可溶性ペプチド粉末12gを得る。
Example 1
100 g of fresh bonito heart arterial spheres are washed with distilled water and the blood inside is removed. The washed arterial sphere is immersed in 0.02N sodium hydroxide solution at room temperature for 3 days to remove the remaining blood. After washing with running water, neutralize with hydrochloric acid, add 3 volumes of distilled water, and sterilize by heating at 95 ° C. Remove the supernatant and remove the collagen along with the lipid. Using this as a raw material for extraction, it is fragmented with a food cutter, added with 1.0% of enzyme Alcalase 2.4L FG, and decomposed in a solution adjusted to pH 8.5 with sodium hydroxide for 6 hours. Add hydrochloric acid to the decomposition product to pH 3, add pepsin (Amano Enzyme) to 1: 10,000, and decompose for 16 hours. Adjust the pH to 4, inactivate the enzyme at a temperature not lower than 85 ° C, purify by layer filtration and then spray dry to obtain 12 g of soluble peptide powder.

実施例2
新鮮なハマチ心臓動脈球100gを蒸留水にて流水洗浄し、内部の血液を除去する。洗浄した動脈球を0.01N水酸化ナトリウム溶液にて常温で3日間浸漬し、残存する血液を除去する。流水洗浄後、3倍容の蒸留水を加えて95℃にて加熱殺菌する。上清を取り除き、脂質と共にコラーゲン質を除去する。これを抽出原料とし、フードカッターにて細片化し、酵素プロチンAC-10F(大和化成製)を0.5%加え、2時間分解、さらに酵素プロテアーゼN「アマノ」G(天野エンサ゛イム製)を0.1%添加し、5時間分解する。85℃以上達温で酵素失活を行い、層濾過にて精製後噴霧乾燥し、可溶性ペプチド粉末7.3gを得る。
Example 2
100 g of fresh Hamachi heart arterial spheres are washed with distilled water and the blood inside is removed. The washed arterial sphere is immersed in 0.01N sodium hydroxide solution at room temperature for 3 days to remove the remaining blood. After washing with running water, add 3 volumes of distilled water and heat sterilize at 95 ° C. Remove the supernatant and remove the collagen along with the lipid. Using this as a raw material for extraction, shred it with a food cutter, add 0.5% of the enzyme protin AC-10F (Daiwa Kasei), decompose for 2 hours, and add 0.1% of the enzyme protease N “Amano” G (Amano Enzyme) And decompose for 5 hours. The enzyme is inactivated at a temperature of 85 ° C or higher, purified by layer filtration and spray-dried to obtain 7.3 g of soluble peptide powder.

実施例3
新鮮なカツオ心臓動脈球100gを蒸留水にて流水洗浄し、内部の血液を除去する。洗浄した動脈球を0.02N水酸化ナトリウム溶液にて常温で3日間浸漬し、残存する血液を除去する。流水洗浄後、3倍容の蒸留水を加えて95℃にて加熱殺菌する。上清を取り除き、脂質と共にコラーゲン質を除去する。0.2Nの塩酸に5日間浸漬し、上清除去後、ペプシンを0.1%添加して37℃にて24時間分解する。NaOHにてpH4とし、85℃以上達温で酵素失活を行い、層濾過にて精製後噴霧乾燥し、可溶性ペプチド粉末10gを得る。
Example 3
100 g of fresh bonito heart arterial spheres are washed with distilled water and the blood inside is removed. The washed arterial sphere is immersed in 0.02N sodium hydroxide solution at room temperature for 3 days to remove the remaining blood. After washing with running water, add 3 volumes of distilled water and heat sterilize at 95 ° C. Remove the supernatant and remove the collagen along with the lipid. Immerse in 0.2N hydrochloric acid for 5 days, remove the supernatant, add 0.1% pepsin and decompose at 37 ° C for 24 hours. The pH is adjusted to 4 with NaOH, the enzyme is inactivated at a temperature not lower than 85 ° C., purified by layer filtration and spray-dried to obtain 10 g of soluble peptide powder.

従来の魚皮由来エラスチンペプチドと比較して、エラスチンの特徴であるデスモシン、イソデスモシン含量の高い酵素分解物を得ることが出来る。また魚コラーゲンとも異なる組成を持つことも確認された。   Compared with a conventional fish skin-derived elastin peptide, an enzyme degradation product having a high content of desmosine and isodesmosine, which is a characteristic of elastin, can be obtained. It was also confirmed to have a composition different from that of fish collagen.

実施例1及び2に従って調製された酵素分解物のアミノ酸組成(mol/1000mol)を下記の表に示す。また比較対照として、マグロ皮より抽出されたペプチドのアミノ酸組成も示した。   The amino acid composition (mol / 1000 mol) of the enzymatic degradation product prepared according to Examples 1 and 2 is shown in the table below. For comparison, the amino acid composition of peptides extracted from tuna skin was also shown.

Figure 2005343851
Figure 2005343851

Claims (4)

エラスチン含有量の高い魚類の弾性繊維により構成される組織を酵素、酸又はアルカリにより分解して得られるペプチド又はその水溶液。   A peptide obtained by decomposing a tissue composed of fish elastic fibers having a high elastin content with an enzyme, acid or alkali, or an aqueous solution thereof. 魚類の弾性繊維により構成される組織は、魚類の動脈球又は他の動脈組織である、請求項1に記載のペプチド又はその水溶液。   The peptide according to claim 1 or an aqueous solution thereof, wherein the tissue composed of elastic fibers of fish is a fish arterial sphere or other arterial tissue. エラスチンに特有のアミノ酸組成を持ち、エラスチンのみに含まれるアミノ酸であるデスモシン、イソデスモシンを、魚皮中に含まれる量より高濃度で含有する、請求項1に記載の魚類由来のペプチド又はその水溶液。   The fish-derived peptide or an aqueous solution thereof according to claim 1, which has an amino acid composition unique to elastin and contains desmosine and isodesmosine, which are amino acids contained only in elastin, in a concentration higher than that contained in fish skin. エラスチン含有量の高い魚類の弾性繊維により構成される組織を酵素、酸又はアルカリにより分解することからなるペプチドの製造方法。   A method for producing a peptide, comprising decomposing a tissue composed of fish elastic fibers having a high elastin content with an enzyme, an acid or an alkali.
JP2004167313A 2004-06-04 2004-06-04 Peptide derived from fishes and method for producing the same Pending JP2005343851A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004167313A JP2005343851A (en) 2004-06-04 2004-06-04 Peptide derived from fishes and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004167313A JP2005343851A (en) 2004-06-04 2004-06-04 Peptide derived from fishes and method for producing the same

Publications (1)

Publication Number Publication Date
JP2005343851A true JP2005343851A (en) 2005-12-15

Family

ID=35496552

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004167313A Pending JP2005343851A (en) 2004-06-04 2004-06-04 Peptide derived from fishes and method for producing the same

Country Status (1)

Country Link
JP (1) JP2005343851A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008074846A (en) * 2006-08-25 2008-04-03 Nippon Meat Packers Inc Elastin decomposition peptide and method for preparing elastin and its zymolytic peptide
JP2010202578A (en) * 2009-03-03 2010-09-16 Hayashikane Sangyo Kk Skin-improving agent, blood vessel function-improving agent, and pharmaceutical composition, food, feed and cosmetic containing them
JP2010239919A (en) * 2009-04-08 2010-10-28 Hagoromo Foods Corp Method for producing elastin-originated peptide, and elastin-originated peptide
JP2010241708A (en) * 2009-04-02 2010-10-28 Yashima Shoji Kk Elastin-containing soluble peptide and method for producing the same
JP2011093872A (en) * 2009-11-03 2011-05-12 Kyushu Institute Of Technology Platelet aggregation inhibitor containing water-soluble elastin derived from fish as active ingredient
JP2012056879A (en) * 2010-09-08 2012-03-22 Kyushu Institute Of Technology Angiotensin-converting enzyme inhibitor and application thereof
JP2013006799A (en) * 2011-06-24 2013-01-10 Taiho Kk Method for producing water-soluble elastin peptide
JP2017528148A (en) * 2015-04-30 2017-09-28 チャイナ ナショナル リサーチ インスティテュート オブ フード アンド ファーメンテーション インダストリーズ Fish protein oligopeptide with low allergenicity and reduced fish odor, industrial preparation method thereof, and use thereof
CN111903985A (en) * 2020-08-11 2020-11-10 安徽盛美诺生物技术有限公司 Preparation method and application of protein oligopeptide rich in desmosine and isodesmosine

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008074846A (en) * 2006-08-25 2008-04-03 Nippon Meat Packers Inc Elastin decomposition peptide and method for preparing elastin and its zymolytic peptide
JP2010202578A (en) * 2009-03-03 2010-09-16 Hayashikane Sangyo Kk Skin-improving agent, blood vessel function-improving agent, and pharmaceutical composition, food, feed and cosmetic containing them
JP2010241708A (en) * 2009-04-02 2010-10-28 Yashima Shoji Kk Elastin-containing soluble peptide and method for producing the same
JP2010239919A (en) * 2009-04-08 2010-10-28 Hagoromo Foods Corp Method for producing elastin-originated peptide, and elastin-originated peptide
JP2011093872A (en) * 2009-11-03 2011-05-12 Kyushu Institute Of Technology Platelet aggregation inhibitor containing water-soluble elastin derived from fish as active ingredient
JP2012056879A (en) * 2010-09-08 2012-03-22 Kyushu Institute Of Technology Angiotensin-converting enzyme inhibitor and application thereof
JP2013006799A (en) * 2011-06-24 2013-01-10 Taiho Kk Method for producing water-soluble elastin peptide
JP2017528148A (en) * 2015-04-30 2017-09-28 チャイナ ナショナル リサーチ インスティテュート オブ フード アンド ファーメンテーション インダストリーズ Fish protein oligopeptide with low allergenicity and reduced fish odor, industrial preparation method thereof, and use thereof
CN111903985A (en) * 2020-08-11 2020-11-10 安徽盛美诺生物技术有限公司 Preparation method and application of protein oligopeptide rich in desmosine and isodesmosine

Similar Documents

Publication Publication Date Title
Ahmed et al. Collagen extraction and recent biological activities of collagen peptides derived from sea-food waste: A review
Coppola et al. Fish waste: From problem to valuable resource
Karayannakidis et al. Fish processing by-products as a potential source of gelatin: A review
Huda et al. Fish bone and scale as a potential source of halal gelatin
KR100381741B1 (en) Collagen product containing collagen of marine origin with a low odor and with improved mechanical properties, and its use in the form of cosmetic or pharmaceutical compositions or products
Sampath Kumar et al. Wound healing properties of collagen from the bone of two marine fishes
KR101071338B1 (en) Method of Producing Collagen Peptide from Marine Organism and Collagen Peptide Produced by the Method
JP2007151453A (en) Soluble peptide highly containing elastin and method for producing the same
Valenzuela-Rojo et al. Tilapia (Oreochromis aureus) collagen for medical biomaterials
Oslan et al. Extraction and Characterization of Bioactive Fish By‐Product Collagen as Promising for Potential Wound Healing Agent in Pharmaceutical Applications: Current Trend and Future Perspective
JP2015042688A (en) Blood vessel improving agent
Chen et al. Collagens made from giant salamander (Andrias davidianus) skin and their odorants
Prajaputra et al. Exploring marine collagen: Sustainable sourcing, extraction methods, and cosmetic applications
KR20140122532A (en) A method for extracting high purity collagen from animal byproducts
JP2005343851A (en) Peptide derived from fishes and method for producing the same
KR100679712B1 (en) Process for preparing collagen from starfish
Benjakul et al. Byproducts from fish harvesting and processing
Chiarelli et al. The emergence of jellyfish collagen: A comprehensive review on research progress, industrial applications, and future opportunities
Gaikwad et al. Fish By-Product Collagen Extraction Using Different Methods and Their Application
JP2006151847A (en) Collagen peptide composition, method for producing the same and cosmetic composition
Ramakrishnan et al. Salmon processing discards: a potential source of bioactive peptides–a review
Pateiro et al. Extraction of valuable compounds from meat by-products
Mora et al. Meat by-products: New insights into potential technical and health applications
Kıyak et al. Advanced technologies for the collagen extraction from food waste–A review on recent progress
JP2011225495A (en) Vascular endothelial cell protecting agent, and pharmaceutical composition, food and feed containing the same

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20051125

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051209

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20051119

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20060405

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20060518

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060620

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20061107